Taipei Exchange - Delayed Quote TWD

Feng Chi Biotech Corp. (6744.TWO)

17.90
0.00
(0.00%)
At close: 10:25:47 AM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
171,099
171,099
180,578
193,460
182,570
Cost of Revenue
93,948
93,948
99,857
110,016
96,464
Gross Profit
77,151
77,151
80,721
83,444
86,106
Operating Expense
61,028
61,028
56,559
56,378
59,665
Operating Income
16,123
16,123
24,162
27,066
26,441
Net Non Operating Interest Income Expense
2,986
2,986
2,769
1,817
1,281
Pretax Income
20,334
20,334
27,299
30,419
28,059
Tax Provision
3,740
3,740
4,507
5,805
4,924
Net Income Common Stockholders
16,594
16,594
22,792
24,614
23,135
Diluted NI Available to Com Stockholders
16,594
16,594
22,792
24,614
23,135
Basic EPS
1.08
--
1.48
1.60
1.50
Diluted EPS
1.07
--
1.47
1.60
1.50
Basic Average Shares
15,364.82
--
15,400
15,383.75
15,400
Diluted Average Shares
15,508.41
--
15,468
15,383.75
15,455
Total Expenses
154,976
154,976
156,416
166,394
156,129
Net Income from Continuing & Discontinued Operation
16,594
16,594
22,792
24,614
23,135
Normalized Income
16,594
16,594
22,792
24,614
23,135
Interest Income
3,240
3,240
3,094
1,875
1,379
Interest Expense
254
254
325
58
98
Net Interest Income
2,986
2,986
2,769
1,817
1,281
EBIT
20,588
20,588
27,624
30,477
28,157
EBITDA
29,805
29,805
34,838
36,788
36,958
Reconciled Cost of Revenue
93,948
93,948
99,857
110,016
96,464
Reconciled Depreciation
9,217
9,217
7,214
6,311
8,801
Net Income from Continuing Operation Net Minority Interest
16,594
16,594
22,792
24,614
23,135
Normalized EBITDA
29,805
29,805
34,838
36,788
36,958
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/25/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers